Marshall Wace North America’s Seagen Inc. Common Stock SGEN Stock Holding History

Marshall Wace North America’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$148M	Buy	872,262 +197,675	+29%	+$30.8M	0.63%	32
2021 Q2	$107M	Sell	674,587 -39,617	-6%	-$5.89M	0.44%	48
2021 Q1	$99.2M	Buy	714,204 +281,970	+65%	+$45.4M	0.41%	53
2020 Q4	$75.7M	Buy	432,234 +161,135	+59%	+$30M	0.34%	67
2020 Q3	$53.1M	Sell	271,099 -93,191	-26%	-$15.6M	0.34%	67
2020 Q2	$61.9M	Sell	364,290 -424,362	-54%	-$63.3M	0.41%	60
2020 Q1	$91M	Buy	788,652 +87,965	+13%	+$9.74M	0.69%	35
2019 Q4	$80.1M	Buy	+700,687	New	+$74.3M	0.39%	72
2019 Q3	–	Sell	-84,316	Closed	-$5.84M	–	1609
2019 Q2	$5.84M	Buy	+84,316	New	+$5.9M	0.04%	328
2018 Q1	–	Sell	-95,344	Closed	-$5.1M	–	1764
2017 Q4	$5.1M	Buy	+95,344	New	+$5.57M	0.03%	571
2017 Q3	–	Sell	-374,220	Closed	-$19.5M	–	1564
2017 Q2	$19.5M	Buy	374,220 +352,280	+1,606%	+$22.4M	0.14%	186
2017 Q1	$1.38M	Buy	+21,940	New	+$1.37M	0.01%	646

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's SGEN Position: Q3 2021 in Review

Marshall Wace North America increased its Seagen Inc. Common Stock (SGEN) stake by 29% in Q3 2021, buying an estimated $30.8M and bringing the position to 872,262 shares worth $148M. The position accounts for 0.63% of the portfolio, ranked #32.

Marshall Wace North America first reported a position in SGEN in Q1 2017 and has held it in 12 quarters since. 483 funds tracked by Wall St. Rank hold SGEN as of Q3 2021.

Marshall Wace North America held 872,262 shares of Seagen Inc. Common Stock worth $148M as of Q3 2021.
Marshall Wace North America bought 197,675 Seagen Inc. Common Stock shares in Q3 2021, an estimated $30.8M.
Seagen Inc. Common Stock made up 0.63% of Marshall Wace North America's portfolio in Q3 2021, its #32 holding.
Marshall Wace North America first reported a position in Seagen Inc. Common Stock in Q1 2017 and has held it in 12 quarters since.
483 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.